Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 3/20 | 0.57 |
| ▸ | HTR2A | P28223 | 6/20 | 0.43 |
| ▸ | HTR7 | P34969 | 4/20 | 0.43 |
| ▸ | HTR1A | P08908 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TTK | P33981 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 3/20 | 0.39 |
| ▸ | HTR2B | P41595 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30566011 | 1.00 | HTR6 (0.57) | HTR6HTR2AHTR7HTR1AKDM4E | |
| SCHEMBL25292178 | 0.86 | ALDH1A1 (0.45) | HTR6HTR2AHTR7HTR1AKDM4E | |
| SCHEMBL25251586 | 0.85 | HTR6 (0.41) | HTR6HTR2AKDM4EALDH1A1HPGD | |
| SCHEMBL25249419 | 0.85 | HTR6 (0.41) | HTR6HTR2AHTR7HTR1AKDM4E | |
| SCHEMBL30566020 | 0.85 | HTR6 (0.41) | HTR6HTR2AKDM4EALDH1A1HPGD | |
| SCHEMBL30565927 | 0.82 | HTR2A (0.55) | HTR6HTR2AKDM4EALDH1A1HPGD | |
| SCHEMBL25243365 | 0.82 | HTR2A (0.55) | HTR6HTR2AKDM4EALDH1A1HPGD | |
| SCHEMBL26811444 | 0.82 | HTR2A (0.62) | HTR6HTR2AHTR1A | |
| SCHEMBL31411452 | 0.81 | HTR1A (0.59) | HTR6HTR2AHTR7HTR1AHTR2C | |
| SCHEMBL5335320 | 0.80 | HTR2A (0.43) | HTR6HTR2AALDH1A1HPGDTTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735425-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2026-05-06 | — | — | EP | disclosed |
| US-20250353818-A1 | Compounds | Psylo Pty Ltd (AU) | 2025-11-20 | — | — | US | disclosed |
| US-12428380-B2 | Compounds | Psylo Pty Ltd (AU) | 2025-09-30 | — | — | US | disclosed |
| US-20250214943-A1 | Compounds | Psylo Pty Ltd (AU) | 2025-07-03 | — | — | US | disclosed |
| US-20250163044-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2025-05-22 | — | — | US | disclosed |
| WO-2025000053-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2025-01-02 | — | — | WO | disclosed |
| EP-4452979-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2024-10-30 | — | — | EP | disclosed |
| WO-2023218423-A1 | INDAZOLES AND THEIR USE IN METHODS FOR TREATING 5-HT2 RESPONSIVE CONDITIONS | ELEUSIS THERAPEUTICS US, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023115165-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023115165-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2023-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214943-A1 | Compounds | NLN, SLC18A2, PYGB | HTR6 54/4885HTR2A 94/4885HTR7 192/4885 |
| US-12428380-B2 | Compounds | NLN, SLC18A2, PYGB | HTR6 54/4885HTR2A 94/4885HTR7 192/4885 |
| US-20250163044-A1 | COMPOUNDS | NLN, SLC18A2, PYGB | HTR6 54/4885HTR2A 94/4885HTR7 192/4885 |
| US-20250353818-A1 | Compounds | NLN, SLC18A2, PYGB | HTR6 54/4885HTR2A 94/4885HTR7 192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.